Oral GLP-1s (Lillys paltusotine-orforglipron, etc.) are expected in late 2025/2026, and might be covered differently (some plans treat orals less restrictively than injectables)
Step 1 - Complete the Intake Form (approximately 3 minutes) You'll answer questions on LIV Body's secure intake form covering your health profile, weight history, current medications, and relevant medical conditions
& Cullen, J
Contact your GP or prescribing clinician for persistent injection site reactions with spreading redness or pain, new or changing skin lesions (especially pigmented ones), severe allergic reactions (facial swelling, difficulty breathing, widespread rash requiring 999/A&E), unexplained rashes or itching, or signs of nutritional deficiency such as poor wound healing or easy bruising
The absence of visible tanning during this phase is not protocol failure